Susan M. Kanaya
Net Worth

Last updated:

What is Susan M. Kanaya net worth?

The estimated net worth of Ms. Susan M. Kanaya is at least $45,129,630 as of 16 Aug 2022. She owns shares worth $4,747,571 as insider, has earned $30,531,049 from insider trading and has received compensation worth at least $9,851,010 in ChemoCentryx, Inc..

What is the salary of Susan M. Kanaya?

Ms. Susan M. Kanaya salary is $757,770 per year as Executive Vice President, Chief Financial & Admin. Officer, Sec. and Director in ChemoCentryx, Inc..

How old is Susan M. Kanaya?

Ms. Susan M. Kanaya is 62 years old, born in 1963.

What stocks does Susan M. Kanaya currently own?

As insider, Ms. Susan M. Kanaya owns shares in one company:

Company Title Shares Price per share Total value
ChemoCentryx, Inc. (CCXI) Executive Vice President, Chief Financial & Admin. Officer, Sec. and Director 91,317 $51.99 $4,747,571

What does ChemoCentryx, Inc. do?

ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of patients with severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy, and lupus nephritis. In addition, it develops CCX559, an orally administered inhibitor for programmed death protein 1/programmed death-ligand 1 for the treatment of various cancers; and CCX507, an orally administered inhibitor of the chemokine receptor known as CCR9, which has completed Phase I clinical trial for the treatment of inflammatory bowel disease. Further, the company has early-stage drug candidates that targets Th17 driven diseases and CCR6. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in San Carlos, California. As of October 20, 2022, ChemoCentryx, Inc. operates as a subsidiary of Amgen Inc.

CCXI logo
CCXI
ChemoCentryx, Inc.
$51.99

Susan M. Kanaya insider trading

ChemoCentryx, Inc.

Ms. Susan M. Kanaya has made 48 insider trades between 2012-2022, according to the Form 4 filled with the SEC.

The largest trade she's ever made was exercising 311,625 units of CCXI stock on 26 Nov 2019. As of 16 Aug 2022 she still owns at least 91,317 units of CCXI stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 19,898 $10.86 $216,092
Option
Stock Option (right to buy) 19,898 $10.86 $216,092
Sale
Common Stock 19,898 $50.95 $1,013,803
Option
Stock Option (right to buy) 14,583 $6.23 $90,852
Option
Stock Option (right to buy) 31,715 $6.62 $209,953
Sale
Common Stock 46,298 $50.17 $2,322,724
Option
Common Stock 31,715 $6.62 $209,953
Option
Common Stock 14,583 $6.23 $90,852
Option
Restricted Stock Units 30,799 N/A N/A
Option
Common Stock 30,799 N/A N/A
Option
Common Stock 30,333 N/A N/A
Option
Restricted Stock Units 30,333 N/A N/A
Sale
Common Stock 50,000 $64.58 $3,229,050
Option
Stock Option (right to buy) 50,000 $9.61 $480,250
Option
Common Stock 50,000 $9.61 $480,250
Option
Stock Option (right to buy) 10,750 $5.47 $58,835
Option
Common Stock 10,750 $5.47 $58,835
Option
Stock Option (right to buy) 20,123 $54.73 $1,101,231
Option
Common Stock 20,123 $54.73 $1,101,231
Sale
Common Stock 20,123 $54.73 $1,101,231
Sale
Common Stock 54,877 $8.19 $449,443
Option
Common Stock 54,877 $8.19 $449,443
Option
Stock Option (right to buy) 54,877 $8.19 $449,443
Option
Common Stock 24,200 $10.86 $262,812
Option
Stock Option (right to buy) 24,200 $10.86 $262,812
Sale
Common Stock 24,200 $50.34 $1,218,301
Option
Stock Option (right to buy) 45,300 $9.53 $431,483
Option
Common Stock 45,300 $9.53 $431,483
Sale
Common Stock 45,300 $49.61 $2,247,152
Sale
Common Stock 2,500 $49.51 $123,775
Option
Stock Option (right to buy) 2,500 $9.53 $23,813
Option
Common Stock 2,500 $9.53 $23,813
Sale
Common Stock 3,000 $49.5 $148,509
Option
Common Stock 3,000 $9.53 $28,575
Option
Stock Option (right to buy) 3,000 $9.53 $28,575
Option
Stock Option (right to buy) 99,617 $45.1 $4,492,229
Sale
Common Stock 99,617 $45.1 $4,492,229
Option
Common Stock 99,617 $45.1 $4,492,229
Sale
Common Stock 3,837 $14.31 $54,907
Option
Common Stock 3,837 $14.31 $54,907
Option
Stock Option (right to buy) 3,837 $14.31 $54,907
Option
Stock Option (right to buy) 15,737 $41.03 $645,736
Option
Common Stock 15,737 $41.03 $645,736
Sale
Common Stock 15,737 $41.03 $645,736
Option
Common Stock 47,261 $14.28 $674,887
Option
Stock Option (right to buy) 47,261 $14.28 $674,887
Sale
Common Stock 47,261 $14.28 $674,887
Option
Common Stock 33,334 N/A N/A
Option
Restricted Stock Units 33,334 N/A N/A
Option
Common Stock 79,019 $9.62 $760,163
Option
Stock Option (right to buy) 74,850 $10.12 $757,781
Sale
Common Stock 311,625 $31.62 $9,852,336
Option
Common Stock 311,625 $6.77 $2,108,766
Option
Stock Option (right to buy) 267,445 $6.7 $1,791,882
Option
Restricted Stock Units 33,334 N/A N/A
Option
Common Stock 33,334 N/A N/A
Option
Stock Option (right to buy) 35,000 $3.57 $124,950
Option
Common Stock 35,000 $3.57 $124,950
Sale
Common Stock 35,000 $3.57 $124,950
Option
Common Stock 3,037 $3.57 $10,842
Option
Stock Option (right to buy) 3,037 $3.57 $10,842
Option
Stock Option (right to buy) 37,893 $3.57 $135,278
Sale
Common Stock 37,893 $3.57 $135,278
Option
Common Stock 37,893 $3.57 $135,278
Option
Restricted Stock Units 43,333 N/A N/A
Option
Common Stock 43,333 N/A N/A
Option
Common Stock 33,333 N/A N/A
Option
Restricted Stock Units 33,333 N/A N/A
Option
Stock Option (right to buy) 100 $3.57 $357
Sale
Common Stock 100 $3.57 $357
Option
Common Stock 100 $3.57 $357
Sale
Common Stock 42,500 $13.75 $584,375
Option
Common Stock 49,507 $13.88 $687,009
Option
Stock Option (right to buy) 49,507 $13.88 $687,009
Option
Stock Option (right to buy) 49,150 $13.25 $651,238
Sale
Common Stock 49,150 $13.25 $651,238
Option
Common Stock 49,150 $13.25 $651,238
Sale
Common Stock 850 $6 $5,100
Option
Stock Option (right to buy) 850 $6 $5,100
Option
Common Stock 850 $6 $5,100
Option
Stock Option (right to buy) 8,306 $6 $49,836
Sale
Common Stock 8,306 $6 $49,836
Option
Common Stock 8,306 $6 $49,836
Option
Common Stock 65,328 $6 $391,968
Option
Stock Option (right to buy) 65,328 $6 $391,968
Sale
Common Stock 65,328 $6 $391,968
Option
Stock Option (right to buy) 1,366 $6 $8,196
Option
Common Stock 1,366 $6 $8,196
Sale
Common Stock 1,366 $6 $8,196
Option
Common Stock 33,333 N/A N/A
Option
Restricted Stock Units 33,333 N/A N/A
Option
Common Stock 33,333 N/A N/A
Option
Restricted Stock Units 33,333 N/A N/A
Option
Restricted Stock Units 20,000 N/A N/A
Option
Common Stock 20,000 N/A N/A
Sale
Common Stock 15,127 $4.06 $61,431
Option
Common Stock 15,127 $4.06 $61,431
Option
Stock Option (right to buy) 15,127 $4.06 $61,431
Option
Stock Option (right to buy) 10,637 $2 $21,274
Sale
Common Stock 10,637 $2 $21,274
Option
Common Stock 10,637 $2 $21,274
Option
Common Stock 14,971 $4.1 $61,336
Option
Stock Option (right to buy) 14,971 $4.1 $61,336
Sale
Common Stock 14,971 $4.1 $61,336
Option
Common Stock 6,134 $4.05 $24,824
Option
Stock Option (right to buy) 6,134 $4.05 $24,824
Sale
Common Stock 6,134 $4.05 $24,824
Option
Stock Option (right to buy) 300 $2 $600
Sale
Common Stock 300 $2 $600
Option
Common Stock 300 $2 $600
Sale
Common Stock 10,224 $2 $20,448
Option
Stock Option (right to buy) 10,224 $2 $20,448
Option
Common Stock 10,224 $2 $20,448
Option
Common Stock 2,776 $6.55 $18,194
Option
Stock Option (right to buy) 2,776 $6.55 $18,194
Sale
Common Stock 2,776 $6.55 $18,194
Sale
Common Stock 34,341 $6.9 $236,884
Option
Stock Option (right to buy) 34,341 $6.9 $236,884
Option
Common Stock 34,341 $6.9 $236,884
Sale
Common Stock 10,490 $2 $20,980
Option
Common Stock 10,490 $2 $20,980
Option
Stock Option (right to buy) 10,490 $2 $20,980
Option
Common Stock 36,942 $2 $73,884
Option
Employee Stock Option (right to buy) 36,942 $2 $73,884
Sale
Common Stock 36,942 $2 $73,884
Option
Common Stock 10,653 $14.28 $152,135
Option
Employee Stock Option (right to buy) 10,653 $14.28 $152,135
Sale
Common Stock 10,653 $14.28 $152,135
Sale
Common Stock 2,117 $2 $4,234
Option
Employee Stock Option (right to buy) 2,117 $2 $4,234
Option
Common Stock 2,117 $2 $4,234
Option
Common Stock 799 $2 $1,598
Sale
Common Stock 799 $2 $1,598
Option
Employee Stock Option (right to buy) 799 $2 $1,598
Sale
Common Stock 1,989 $2 $3,978
Option
Employee Stock Option (right to buy) 1,989 $2 $3,978
Option
Common Stock 1,989 $2 $3,978
Option
Employee Stock Option (right to buy) 666 $6.96 $4,633
Option
Common Stock 666 $6.96 $4,633
Sale
Common Stock 441 $2 $882
Sale
Common Stock 2,709 $11.89 $32,215
Option
Common Stock 5,487 $11.89 $65,246
Option
Employee Stock Option (right to buy) 5,487 $11.89 $65,246
Sale
Common Stock 2,921 $11.92 $34,824
Option
Employee Stock Option (right to buy) 6,122 $11.92 $72,986
Option
Common Stock 6,122 $11.92 $72,986
Sale
Common Stock 3,929 $2 $7,858
Option
Common Stock 7,725 $6.96 $53,766
Option
Employee Stock Option (right to buy) 7,725 $6.96 $53,766
Option
Employee Stock Option (right to buy) 4,693 $11.98 $56,217
Option
Common Stock 4,693 $11.98 $56,217
Sale
Common Stock 4,693 $11.98 $56,217
Sale
Common Stock 404 $11.93 $4,818
Option
Common Stock 404 $11.93 $4,818
Option
Employee Stock Option (right to buy) 404 $11.93 $4,818
Option
Common Stock 830 $2 $1,660
Sale
Common Stock 830 $2 $1,660
Option
Employee Stock Option (right to buy) 830 $2 $1,660
Option
Common Stock 3,839 $11.89 $45,661
Sale
Common Stock 3,839 $11.89 $45,661
Option
Employee Stock Option (right to buy) 3,839 $11.89 $45,661
Sale
Common Stock 234 $2 $468
Option
Employee Stock Option (right to buy) 234 $2 $468
Option
Common Stock 234 $2 $468
Sale
Common Stock 16,029 $6.95 $111,321
Option
Employee Stock Option (right to buy) 16,029 $6.95 $111,321
Option
Common Stock 16,029 $6.95 $111,321
Option
Common Stock 3,971 $2 $7,942
Sale
Common Stock 3,971 $2 $7,942
Option
Employee Stock Option (right to buy) 3,971 $2 $7,942

ChemoCentryx key executives

ChemoCentryx, Inc. executives and other stock owners filed with the SEC: